Solid-Phase Extraction and Enhanced Amplification-Free Detection of Pathogens Integrated by Multifunctional CRISPR-Cas12a
ACS Applied Materials & Interfaces · 2024-03-27 · 16 (12) · 14445-14456
DOI: 10.1021/acsami.3c17039 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, published online on 2024-03-12. Written by Zimu Tian and 2 co-authors. Institution: Department of Chemistry, University of Florida, Gainesville, Florida 32611, United States. Major MEDLINE topics: Nucleic Acids, Biosensing Techniques. Cited 24 times so far (Crossref); 53 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS, National Cancer Institute.
Abstract (original language)
Public healthcare demands effective and pragmatic diagnostic tools to address the escalating challenges in infection management in resource-limited areas. Recent advances in clustered regularly interspaced short palindromic repeat (CRISPR)-based biosensing promise the development of next-generation tools for disease diagnostics, including point-of-care (POC) testing for infectious diseases. The currently prevailing strategy of developing CRISPR/Cas-based diagnostics exploits only the target identification and trans-cleavage activity of a CRISPR-Cas12a/Cas13a system to provide diagnostic results, and they need to be combined with an additional preamplification reaction to enhance sensitivity. In contrast to this dual-function strategy, here, we present a new approach that collaboratively integrates the triple functions of CRISPR-Cas12a: target identification, sequence-specific enrichment, and signal generation. With this approach, we develop a nucleic acid assay termed Solid-Phase Extraction and Enhanced Detection Assay integrated by CRISPR-Cas12a (SPEEDi-CRISPR) that negates the need for preamplification but significantly improves the detection of limit (LOD) from the pM to fM level. Specifically, using Cas12a-coated magnetic beads, this assay combines efficient solid-phase extraction and enrichment of DNA targets enabled by the sequence-specific affinity of CRISPR-Cas12a with fluorogenic detection by activated Cas12a on beads. SPEEDi-CRISPR, for the first time, leverages the possibility of employing CRISPR/Cas12a in nucleic acid extraction and integrates the ability of both enrichment and detection of CRISPR/Cas into a single platform. Our proof-of-concept studies revealed that the SPEEDi-CRISPR assay has great specificity to distinguish HPV-18 from HPV-16, and Parvovirus B19, in addition to being able to detect HPV-18 at a concentration as low as 2.3 fM in 100 min and 4.7 fM in 60 min. Furthermore, we proved that this assay can be coupled with two point-of-care testing strategies: the smartphone-based fluorescence detector and the lateral flow assay. Overall, these results suggested that our assay could pave a new way for developing CRISPR diagnostics.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Chemistry, University of Florida, Gainesville, Florida 32611, United States.
- J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, Florida 32611, United States.
- University of Florida Health Cancer Center, Gainesville, Florida 32611, United States.
Funding
- NCI NIH HHS
- National Cancer Institute
Cite
APA
Tian, Z., Yan, H., & Zeng, Y. (2024). Solid-Phase Extraction and Enhanced Amplification-Free Detection of Pathogens Integrated by Multifunctional CRISPR-Cas12a. ACS Applied Materials & Interfaces, 16(12), 14445-14456. https://doi.org/10.1021/acsami.3c17039
Vancouver
Tian Z, Yan H, Zeng Y. Solid-Phase Extraction and Enhanced Amplification-Free Detection of Pathogens Integrated by Multifunctional CRISPR-Cas12a. ACS Applied Materials & Interfaces. 2024;16(12):14445-14456. doi:10.1021/acsami.3c17039
BibTeX
@article{Tian2024,
author = {Tian, Zimu and Yan, He and Zeng, Yong},
title = {Solid-Phase Extraction and Enhanced Amplification-Free Detection of Pathogens Integrated by Multifunctional CRISPR-Cas12a},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
volume = {16},
number = {12},
pages = {14445--14456},
doi = {10.1021/acsami.3c17039}
}
EUVIMED